DRAFT PROGRAMME

February 17, 2014 09:00 – 16:30 Hrs Workshop 1 Venture Capital & Private Equity in Life Sciences & Healthcare

09:00 - 16:30 Hrs Workshop 2 Master Class on Bio-entrepreneurship – Accelerating Innovation to Marketplace

08:30 – 16:30 Hrs BioPark Visit

17:00 – 18:00 Inaugural Ceremony

18:30 – 19:30

Keynote Addresses India’s vision and path to become the Innovation Hub – Opportunities Dr. K. Vijay Raghavan, Secretary to the Government of India, Department of Biotechnology* Global Life Sciences Innovation Landscape – Where are we and what next? Mr. Chris Stirling, Global Head of Life Sciences, KPMG, UK Spurring Innovations - Success story of Flemish Institute of Biotechnology Dr. Johan Cardoen, Managing Director, Flemish Institute of Biotechnology, Belgium

19:30 – 21:00 Gala Reception (Only for registered delegates)

February 18, 2014 10:00 – 11:30 Panel Discussion

Creating an Innovation EcoSystem Role of Industry, Academia, Government, Investors and Service Providers, Science Parks and others Chairman: Dr. Ajit Shetty, Corporate Vice President (Global Operations) Retd. and Chairman Emeritus, Janssen Pharmaceutica (J&J), Belgium Panelists:

Prof. Seyed E. Hasnain, Director (Bio), IIT Delhi and Member, PM Scientific Advisory Council

Dr. TAN Geok Leng, Executive Director (Science and Engineering Research Council), A*STAR, Singapore*

Dr. Renu Swaroop, Managing Director, DBT-BIRAC, Government of India

Ms. Deepanwita Chattopadhyay, CEO, IKP Knowledge Park* Representative from Imperial College of London/University

of Cambridge, UK

Moderator – To be identified

Session Sponsored by DBT-BIRAC

Technology Tracks

1. Drug Discovery 2. BioEnergy 3. BioTherapeutics

Exhibition

and Partnering

11:30 – 12:00 Break 12:00 – 13:30 Panel Discussion

Models for enhancing Lifesciences R&D Efficiencies Collaborative and External R&D, R&D Initiatives that will reduce the cost and time from concept to cure, Partnerships

Chair and Keynote Speaker - Dr. Bill Hait, Global Head R&D, Janssen Pharmaceutica (J&J), USA

Panelists: Dr. Pankaj Patel, Chairman and MD, Zydus Cadila* Dr. Uwe Schoenbeck, Chief Scientific Officer and Head of

External R&D Innovation, Worldwide R&D, Pfizer Dr. Phil Kearney, Director, Licensing and External Research,

MSD, Australia Dr. Steve Yang, Asia Head (R&D), AstraZeneca, China* Dr. Subir Basak, President - Global Drug Discovery, Jubilant

Lifesciences

Moderator – Mr. Utkarsh Palnitkar, National Head of Life Sciences, KPMG, India

13:30 - 15:00 Lunch 15:00 – 16:30 Panel Discussion

Intellectual Property Regime - Barrier or Incentive?

Panelists: Dr. Yusuf Khwaja Hamied, Chairman, Cipla* Dr. Ranjit Shahani, CEO, Novartis India Dr. AKS Bhujanga Rao, President(R&D & Technology), Natco

Pharma* Mr. Chaitanya Prasad, IAS, Controller General of Patents,

Designs & Trade Marks, India* Mr. Guriqbal Singh Jaiya, Advisor to DDG (Innovation &

Technology), World Intellectual Property Organization (WIPO), Switzerland

Representative from Japan Patent Office

Moderator – To be identified

16:30 – 18:00 Fireside Chat with Indian Health Regulators Officials from Ministry of Health, Govt. of India - Secretary

(Shri KN Desiraju)/ Joint Secretary (Dr. Arun Kumar Panda)* Dr. GN Singh, DCGI, Govt. of India*

Moderator – Mr. Vikas Dandekar, India Bureau Chief, Elsevier Business Intelligence

Coordinated by Pharmexcil

18:30 – 20:00 CEO Conclave (Only by Invitations) Is Innovations a viable business model for India?

Mr. Abbas Hussain, President (MENA) and Executive Board Member, GSK, UK Dr. Glenn Saldhana, CEO, Glenmark Pharmaceuticals Mr. Rehan Khan, MD, Abbott, India Dr. Edgard Olaizola, MD (India and Sri Lanka), Lilly India Dr. GV Prasad, Chairman & CEO, Dr. Reddy’s Laboratories Ltd.* Mr. Aijaz Tobaccowala, MD, Pfizer India*

Moderator – Anchor from CNBC

20:00 – 21:00 CEO Conclave Dinner Reception February 19, 2014

10:30-11:30 Plenary Address Open Innovation and R&D

Panelists: Dr. T S Balganesh, Head, Open Source Drug Discovery

Initiative, CSIR, Government of India Dr. Abhijit Barve, President, R&D, Biocon Ltd.* Dr. Rasmus Rojkjaer, Vice President and Head of Global

Biologics R&D, Mylan Pharmaceuticals, Switzerland Dr. Toshiyuki Mori, Director, Alliance Group, Pharmaceutical

Research Division, Takeda Pharmaceutical Co. Ltd., Japan Dr. Bapoing Wang, Managing Director, Novo Nordisk, China Representative from Lilly GERD

Moderator – To be identified

Session Sponsored by Jubilant Life Sciences

Technology Tracks 1. Bio-IT 2. Medical

Electronics and Devices

3. Regenerative Medicine

Exhibition

and Partnering

11:30 – 12:00 Break 12:00 – 13:30 Panel Discussion

First-Mover Advantage: The Case for Investing in Life Science

Panelists: Dr. Anula Jayasuriya, Co-founder, Evolvence India Life

Science Fund, USA Representative from 5 AM Ventures, USA* Mr. Nitin Deshmuk, Kotak PE, India* Mr. Prem Pavoor, Director, Fidelity Capital Partners* Mr. Srinivas Alluri, MD – India (PE), Morgan Stanley* Representative from Amgen Ventures / Merck Ventures* Dr. Anand Anandkumar, CEO, Cellworks*

13:30 - 15:00 Lunch

15:00 – 16:30 Panel Discussion Innovations and the 3A challenges (Accessibility, Affordability and Availability)

Chairman: Dr. VM Katoch, Director General, ICMR*

Panelists: Smt. Aradhana Johri IAS, Secretary, Department of

Pharmaceutical, Government of India* Dr. J Radhakrishnan IAS, Principal Secretary (Health),

Government of Tamil Nadu* Dr. Vivek Ahuja, Director, Clinical Research & Development,

PATH (Program for Appropriate Technology in Health),India Dr. Cyrus Karkaria, President (Biotech), Lupin Pharma* Dr. Krishna Ella, Chairman and Managing Director, Bharat

Biotech Intl. Ltd*

Moderator – To be identified

16:30 – 17:30 Valedictory Ceremony and Event Close *Yet to be confirmed/Invited